We are developing potential medicines that improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Cardiovascular diseases are the leading cause of death in the U.S. and in many places around the world. We’re focused on finding potential treatments for people with heart failure and hypertrophic cardiomyopathy.
Neuromuscular diseases can cause loss of muscle function, muscle weakness and fatigue. Our goal is develop potential therapies for people with amyotrophic lateral sclerosis and spinal muscular atrophy.
- Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at the American Heart Association Scientific Sessions 2019
- Cytokinetics Announces Pricing of Public Offering of Convertible Senior Notes
- Cytokinetics Announces Proposed Public Offering of Convertible Senior Notes